Circadian clock resetting in the mouse changes with age

被引:0
作者
Stephany M. Biello
机构
[1] University of Glasgow,Department of Psychology
来源
AGE | 2009年 / 31卷
关键词
Circadian; Brain slice; Suprachiasmatic;
D O I
暂无
中图分类号
学科分类号
摘要
The most widely recognised consequence of normal age-related changes in biological timing is the sleep disruption that appears in old age and diminishes the quality of life. These sleep disorders are part of the normal ageing process and consist primarily of increased amounts of wakefulness and reduced amounts of deep sleep. Changes in the amplitude and timing of the sleep-wake cycle appear to represent, at least in part, a loss of effective circadian regulation of sleep. Understanding alterations in the characteristics of stimuli that help to consolidate internal rhythms will lead to recommendations to improve synchronisation in old age. Converging evidence from both human and animal studies indicate that senescence is associated with alterations in the neural structure thought to be primarily responsible for the generation of the circadian oscillation, the suprachiasmatic nuclei (SCN). Work has shown that there are changes in the anatomy, physiology and ability of the clock to reset in response to stimuli with age. Therefore it is possible that at least some of the observed age-related changes in sleep and circadian timing could be mediated at the level of the SCN. The SCN contain a circadian clock whose activity can be recorded in vitro for several days. We have tested the response of the circadian clock to a number of neurochemicals that reset the clock in a manner similar to light, including glutamate, N-methyl-D-aspartate (NMDA), gastrin-releasing peptide (GRP) and histamine (HA). In addition, we have also tested agents which phase shift in a pattern similar to behavioural ‘non-photic’ signals, including neuropeptide Y (NPY), serotonin (5HT) and gamma-aminobutyric acid (GABA). These were tested on the circadian clock in young and older mice (approximately 4 and 15 months old). We found deficits in the response to specific neurochemicals but not to others in our older mice. These results indicate that some changes seen in the responsiveness of the circadian clock to light with age may be mediated at the level of the SCN. Further, the responsiveness of the circadian clock with age is attenuated to some, but not all stimuli. This suggests that not all clock stimuli loose their effectiveness with age, and that it may be possible to compensate for deficits in clock performance by enhancing the strength of those stimulus pathways which are intact.
引用
收藏
页码:293 / 303
页数:10
相关论文
共 254 条
[1]  
Albers HE(1995)Analysis of the phase shifting effects of gastrin releasing peptide when microinjected into the suprachiasmatic region Neurosci Lett 191 63-66
[2]  
Gillespie CF(2005)AGABAergic mechanism is necessary for coupling dissociable ventral and dorsal regional oscillators within the circadian clock Curr Biol 15 886-893
[3]  
Babagbemi TO(2003)Response of the mouse circadian system to serotonin IA/2/7 agonists in vivo: surprisingly little J Biol Rhythms 18 145-158
[4]  
Huhman KL(2006)GABAand Gi/o differentially control circadian rhythms and synchrony in clock neurons Proc Natl Acad Sci USA 103 19188-19193
[5]  
Albus H(2001)Circadian rhythms in firing rate of individual suprachiasmatic nucleus neurons from adult and middle-aged mice Neurosci 106 255-261
[6]  
Vansteensel MJ(2006)Age-related effects on the biological clock and its behavioural output in a primate Chronobiol Int 23 451-460
[7]  
Michel S(1997)Light-induced phase shifts of circadian activity rhythms and immediate early gene expression in the suprachiasmatic nucleus are attenuated in old C3H/HeN mice Brain Res 747 34-42
[8]  
Block GD(2001)MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro Brain Res 920 202-209
[9]  
Meijer JH(1994)Neuropeptide Y and behaviorally induced phase shifts Neurosci 62 273-279
[10]  
Antle MC(1997)Neuropeptide Y and glutamate block each other’s phase shifts in the suprachiasmatic nucleus in vitro Neurosci 77 1049-1058